ADCT vs PG · rev $70.8M vs P/E 25, rev $84.28B
ADC Therapeutics SA (ADCT) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
ADC Therapeutics SA (ADCT) is a biotechnology company listed on NYSE.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported ADCT revenue for 2024-12-31 was $70.8M. Net income was -$157.8M. Revenue was up 1.8% from 2023-12-31 to 2024-12-31. ADCT currently screens at market cap $141.2M.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
ADCT currently screens at market cap $141.2M. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the ADCT and PG stock pages for the full models.
Not investment advice.